IN2014MN00363A - - Google Patents

Download PDF

Info

Publication number
IN2014MN00363A
IN2014MN00363A IN363MUN2014A IN2014MN00363A IN 2014MN00363 A IN2014MN00363 A IN 2014MN00363A IN 363MUN2014 A IN363MUN2014 A IN 363MUN2014A IN 2014MN00363 A IN2014MN00363 A IN 2014MN00363A
Authority
IN
India
Prior art keywords
compounds
clathrates
isotopes
prodrugs
solvates
Prior art date
Application number
Inventor
Vidya Ramdas
Moloy Manoj Banerjee
Advait Arun Joshi
Rajeshkumar Maganlal Loriya
Ganesh Navinchandra Gote
Venkata P Palle
Rajender Kumar Kamboj
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Priority to IN363MUN2014 priority Critical patent/IN2014MN00363A/en
Priority claimed from PCT/IB2012/054381 external-priority patent/WO2013030750A1/en
Publication of IN2014MN00363A publication Critical patent/IN2014MN00363A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of the general formula (I) their tautomeric forms their stereoisomers their analogs their prodrugs their isotopes their N oxides their metabolites their pharmaceutically acceptable salts polymorphs solvates optical isomers clathrates co crystals combinations with suitable medicament pharmaceutical compositions containing them methods of making of the above compounds and their use as antiviral candidate more specifically as anti HCV are disclosed.
IN363MUN2014 2011-09-01 2012-08-27 IN2014MN00363A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN363MUN2014 IN2014MN00363A (en) 2011-09-01 2012-08-27

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1157KO2011 2011-09-01
PCT/IB2012/054381 WO2013030750A1 (en) 2011-09-01 2012-08-27 Antiviral compounds
IN363MUN2014 IN2014MN00363A (en) 2011-09-01 2012-08-27

Publications (1)

Publication Number Publication Date
IN2014MN00363A true IN2014MN00363A (en) 2015-06-19

Family

ID=54259016

Family Applications (1)

Application Number Title Priority Date Filing Date
IN363MUN2014 IN2014MN00363A (en) 2011-09-01 2012-08-27

Country Status (3)

Country Link
IN (1) IN2014MN00363A (en)
SG (1) SG11201400084XA (en)
ZA (1) ZA201402374B (en)

Also Published As

Publication number Publication date
SG11201400084XA (en) 2014-08-28
ZA201402374B (en) 2015-11-25

Similar Documents

Publication Publication Date Title
MX2016006336A (en) Pyrazolopyrimidine compounds.
IN2014MN02106A (en)
CR20140294A (en) DERIVATIVES OF DIHIDRO-BENZO-OXAZINA AND DIHIDRO-PIRIDO-OXAZINA
IN2014CN04530A (en)
UY32490A (en) BETA-SECRETASA INHIBITORS
CR20130415A (en) HETEROARILO DERIVATIVES AS MODULATORS OF NACHR ALFA 7
IN2014MN01433A (en)
PH12015501363A1 (en) Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
EA201490807A1 (en) NEW SUBSTITUTED IMIDAZOPIRIMIDINES AS GPBAR1 MODULATORS
EA201491362A1 (en) ANESTHYZING COMPOUNDS AND METHODS OF THEIR APPLICATION
AR080878A1 (en) HETEROCICLIC DERIVATIVES OF ARYLETINYL, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, METHOD FOR PREPARING THEM AND USE OF THE SAME IN THE TREATMENT OF CHICHOPHRENIA AND COGNITIVE DISORDERS.
MX362060B (en) Antiviral compounds inhibitors of hcv ns5b.
IN2014MN02598A (en)
TW201613567A (en) Use of gabaa receptor reinforcing agent in preparation of sedative and anesthetic medicament
MX2012000231A (en) Novel azabicyclohexanes.
MY175854A (en) Novel quinolone derivatives
ES2657549T3 (en) Substituted pyridopyrazines as new SYK inhibitors
PH12016500394A1 (en) Polymorphic form of pyrrole derivative and intermediate thereof
IN2015DN01119A (en)
CR20120524A (en) COMBINATIONS CONTAINING 2,3-DIHYDROIMIDAZO [1,2-C] REPLACED QUINAZOLINE
AR088246A1 (en) ETHYLENE DERIVATIVES
MX2013008340A (en) Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer.
JOP20200030A1 (en) Pentacyclic compound
WO2014062838A3 (en) Pkm2 modulators and methods for their use
CO6751286A2 (en) Synthesis of 2-carboxamide-cycloamine-urea derivatives